DWA
AGN

Dorsey Wright & Associates’s Allergan plc AGN Stock Holding History

Dorsey Wright & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,828
Closed -$2.37M – 132
2016
Q1 		$2.37M Sell
8,828
-3,717
-30% -$1.06M 1.25% 22
2015
Q4 		$3.92M Sell
12,545
-8,310
-40% -$2.47M 2.01% 14
2015
Q3 		$5.67M Buy
20,855
+579
+3% +$178K 3% 11
2015
Q2 		$6.02M Sell
20,276
-82
-0.4% -$24.5K 2.91% 12
2015
Q1 		$6.06M Sell
20,358
-12
-0.1% -$3.42K 2.78% 11
2014
Q4 		$5.24M Buy
20,370
+204
+1% +$51K 2.4% 11
2014
Q3 		$4.87M Sell
20,166
-20,900
-51% -$4.68M 0.68% 26
2014
Q2 		$8.53M Buy
41,066
+20,329
+98% +$4.21M 1% 28
2014
Q1 		$4.11M Sell
20,737
-673
-3% -$133K 0.57% 28
2013
Q4 		$3.83M Buy
21,410
+4
+0% +$625 0.55% 28
2013
Q3 		$3.08K Buy
+21,406
New +$2.85M 0.43% 31

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dorsey Wright & Associates's AGN Position: Q2 2016 in Review

Dorsey Wright & Associates sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 8,828 shares — an estimated $2.37M sold.

Dorsey Wright & Associates first reported a position in AGN in Q3 2013 and held it in 11 quarters. The position peaked at $8.53M in Q2 2014. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Dorsey Wright & Associates reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Dorsey Wright & Associates sold 8,828 Allergan plc shares in Q2 2016, an estimated $2.37M.
  • Dorsey Wright & Associates first reported a position in Allergan plc in Q3 2013 and held it in 11 quarters.
  • Dorsey Wright & Associates's Allergan plc position peaked at $8.53M in Q2 2014.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Dorsey Wright & Associates's 13F filing for Q2 2016, filed 21 Jul 2016.